Media
Pharmaceutical Valley News – KangaBio’s Class 1 Novel Drug KGX101 Granted Clinical Trial Approval in China for the Treatment of Solid Tumors
2024-10-16
Media
IN³LAB Tech Dialogue —— Exclusive Interview with Dr. Weidong Jiang, Founder of KangaBio, an Innovative Biopharma Firm Focused on Novel Cancer Immunotherapies
2024-06-13
Media
Pharmaceutical Insight – Exclusive Interview | Dr. Weidong Jiang: KangaBio Secures Over RMB 100 Million in Pre-Series A Financing, What Makes This Emerging Biotech Stand Out?
2023-07-17
Media
Xindao Capital – Exclusive Interview | Dr. Weidong Jiang, Founder of KangaBio: Accelerating Global Innovation at the Forefront
2022-04-19